Elmind Capital, LP
- SEC CIK
- 0002052213
- Latest filing
- Aug 14, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 107,900
- Value
- $1.56M
- % of portfolio
- 0.4%
- Quarters held
- 3
- Since Q4 2025